Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
M Eyerozyma Guilliermondii Species Complex: Review of Current Epidemiology, Antifungal Resistance, and Mechanisms Publisher Pubmed



Ghasemi R1 ; Lotfali E2 ; Rezaei K1 ; Madinehzad SA1 ; Tafti MF1 ; Aliabadi N3 ; Kouhsari E4, 5 ; Fattahi M6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Microbiology Department Islamic, Azad University Tehran Branch, Tehran, Iran
  4. 4. Department of Laboratory Sciences, Faculty of Paramedicine, Golestan University of Medical Sciences, Gorgan, Iran
  5. 5. Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran
  6. 6. Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran

Source: Brazilian Journal of Microbiology Published:2022


Abstract

Meyerozyma guilliermondii has been accepted as a complex composed of Meyerozyma guilliermondii, Meyerozyma carpophila, and Meyerozyma caribbica. M. guilliermondii is a saprophyte detected on human mucosa and skin. It can lead to serious infections in patients with risk factors like chemotherapy, immunodeficiency, gastrointestinal or cardiovascular surgery, and oncology disorders. Most deaths related to M. guilliermondii infections occur in individuals with malignancy. In recent decades, incidence of M. guilliermondii infections is increased. Sensitivity of this microorganism to conventional antifungals (e.g., amphotericin B, fluconazole, micafungin and anidulafungin) was reduced. Prophylactic and empirical uses of these drugs are linked to elevated minimal inhibitory concentrations (MICs) of M. guilliermondii. Drug resistance has concerned many researchers across the world. They are attempting to discover appropriate solution to combat this challenge. This study reviews the most important mechanisms of resistance to antifungals developed by in M. guilliermondii species complex. © 2022, The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.
Other Related Docs
18. Candida Auris, an Emerging Fungal Pathogen, Journal of Mazandaran University of Medical Sciences (2019)